GENE ONLINE|News &
Opinion
Blog

EMA
Policy MonkeypoxVirusEMA
EMA Responds to Monkeypox Public Health Emergency
2022-07-28
COVID-19 New Anti-Cancer Drug
EMA Begins Reviewing Cancer Medicine for COVID-19 Without Manufacturer’s Application
2022-07-28
Regulatory PARP Inhibitor
EMA Recommends Restriction on Rubraca
2022-07-25
Trials & Approvals Novavax
Novavax Requires Extra Warnings One Day After Receiving Emergency Use Authorization
2022-07-18
Trials & Approvals Haemophilia
BioMarin Wins First Gene Therapy Recommendation For Hemophilia A in Europe
2022-06-27
Special ASGCT
Convergence, Communication and Commercialization, The Cornerstones In Emerging Regulatory Trends
2022-05-24
1 2
LATEST
Kaiser’s Data Breach: 13.4 Million Affected in Healthcare Conglomerates Privacy Crisis
2024-04-26
Mechanisms of Allograft Rejection: Insights from Behind the Scenes
2024-04-25
ImmunityBio’s ANKTIVA® Granted FDA Approval: Breakthrough IL-15 Receptor Agonist First-in-Class for BCG-Unresponsive Non-Muscle Invasive Bladder Cancer
2024-04-24
Takeda, Astellas, and Sumitomo Mitsui Banking Declare Agreement For Early Drug Discovery Program Incubation in Joint Venture
2024-04-23
Ochre Bio Announces Partnership with Boehringer Ingelheim to Develop Novel Regenerative Treatments for Patients with Advanced Liver Disease
2024-04-22
Earth Day Awareness: Hospitals Embrace Sustainability Efforts
2024-04-22
WHO Raises Alarm: Bird Flu Threat to Humans an ‘Enormous Concern’
2024-04-19
READ MORE
EVENT
2024-04-27
2024 Biomedical Final Pitch Competition
Room DA1620, Dana Building, Dana-Farber Cancer Institute, 99 Jimmy Fund Way, Boston, MA 02115
SEE MORE
Newsletter

Subscribe to receive updates.

SIGN UP
Facebook
Youtube
Twitter
Linkedin
About
Explore
More
© 2024 GeneOnline
Privacy Policy | Terms of Service
Privacy Policy | Terms of Service
  • Subscribe to our newsletter and dive into the world of biopharma with us.
SIGN UP
x
Scroll to Top